Why Inspect? parenteral injecton visual inspection shandong hawkeye US FDA 483 Themes
Patient Risk
– Physiological Implications
• Particles
– Chemical and Microbiological Implications
• Particles, Container Integrity
• Compendial Requirements
– Pharmacopeias
• Regulatory Requirements
• Process Knowledge and Continuous Process
Improvement
• Must establish a maximum allowable reject rate.
• Must control reinspection of product, including when appropriate, inspection conditions and number of reinspections permitted.
• Inspectors must be trained, and training
documented.
• Inspectors must be periodically requalified.
• Training and qualification conditions must align
with routine 100% inspection conditions.
• Address inspection fatigue during qualification.
• Must use statistically sound sampling plan(s) for AQL inspection.
-0086-13589838190
Comments
Post a Comment